½ÃÀ庸°í¼­
»óǰÄÚµå
1534267

¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Biliary Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 169 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 8,279¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 7¾ï 9,377¸¸ ´Þ·¯ ±Ùó¿¡ ´ÞÇϸç, Á¶»ç ±â°£ 2024-2032³â CAGRÀº 5.68%·Î ÃßÁ¤µË´Ï´Ù.

´ãµµ ½ºÅÙÆ®´Â Æó¼â¼º ´ãµµ Áúȯ ȯÀÚÀÇ ´ã°ü °³ÅëÀ» À¯ÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ½ºÅÙÆ®´Â ÀϹÝÀûÀ¸·Î Á¾¾ç, °á¼® ¹× ÇùÂøÀ¸·Î ÀÎÇÑ ¸·ÈûÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ¸ç ´ã°ü¾Ï, ÃéÀå¾Ï ¹× ´ã°ü °á¼®Áõ°ú °°Àº Áúº´À» °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½ºÅÙÆ®´Â ÀϹÝÀûÀ¸·Î ³»½Ã°æÀ¸·Î »ðÀԵǸç, ÇÃ¶ó½ºÆ½ ¶Ç´Â ±Ý¼Ó(ÀÚ°¡ È®ÀåÇü ±Ý¼Ó ½ºÅÙÆ® µî) µî ´Ù¾çÇÑ ÀçÁú·Î ¸¸µé¾îÁý´Ï´Ù. ÇÃ¶ó½ºÆ½ ½ºÅÙÆ®´Â ÀϹÝÀûÀ¸·Î ´Ü±â°£ °ü¸®¿¡ »ç¿ëµÇ¸ç °¡°ÝÀÌ Àú·ÅÇÏÁö¸¸ ±Ý¼Ó ½ºÅÙÆ®´Â ³»±¸¼ºÀÌ ¶Ù¾î³ª°í ±³Ã¼ÇÒ Çʿ䰡 Àû¾î Àå±â°£ »ç¿ëÇϱ⿡ ÀûÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½ºÅÙÆ®¸¦ »ç¿ëÇϸé Áõ»óÀ» ¿ÏÈ­ÇÏ°í ´ãÁóÀÇ È帧À» °³¼±Çϰí Ȳ´Þ ¹× ´ã°ü¿°°ú °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇÏ¿© ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

´ãµµ ½ºÅÙÆ® ½ÃÀåÀº ÃéÀå¾Ï, ´ã°ü¾Ï µî ´ãµµ Áúȯ ¹× ¾Ï ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇØÁü¿¡ µû¶ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ´ãµµ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ´ãµµ ½ºÅÙÆ® »ðÀÔ¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ´ãµµ Æó¼â¸¦ ¿ÏÈ­Çϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ ´ãµµ ½ºÅÙÆ® ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ºÅÙÆ® µðÀÚÀÎÀÇ ±â¼úÀû ¹ßÀüµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÚ±â È®ÀåÇü ±Ý¼Ó ½ºÅÙÆ®, »ýºÐÇØ¼º ½ºÅÙÆ®, ÄÚÆÃ ±â¼úÀÇ ¹ßÀü°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ´ãµµ ½ºÅÙÆ®ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº ȯÀÚ °á°úÀÇ °³¼±°ú ¼Ö·ç¼ÇÀÇ ¼ö¸í ¿¬ÀåÀ¸·Î À̾îÁ® °í±Þ ½ºÅÙÆ® »ðÀÔ ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ãµµ ÁúȯÀÇ À§ÇèÀ» Áõ°¡½ÃŰ´Â ºñ¸¸°ú ´ç´¢º´°ú °°Àº »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ³»½Ã°æ ¼ö¼úÀÇ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ½Ã¼³ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶ó È®´ë·Î ÀÎÇØ ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä« µîÀÇ Áö¿ª¿¡¼­´Â ÇコÄɾ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ºÅÙÆ® Á¦Á¶¾÷ü¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÆÄÆ®³Ê½ÊÀº ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí Á¦Ç° Á¦°øÀ» °­È­ÇÕ´Ï´Ù. °øµ¿ ¿¬±¸°³¹ß ³ë·ÂÀº ÀÓ»ó °úÁ¦¸¦ ÇØ°áÇϰí ȯÀÚ Ä¡·á¸¦ °³¼±ÇÏ´Â »õ·Î¿î ½ºÅÙÆ® ±â¼úÀÇ µµÀÔÀ¸·Î À̾îÁý´Ï´Ù. ±×·¯³ª ÷´Ü ´ãµµ ½ºÅÙÆ®¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ½ºÅÙÆ® »ðÀÔ ¹× Á¤ºñ¿Í °ü·ÃµÈ ÀáÀçÀûÀÎ ÇÕº´ÁõÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ãµµ ½ºÅÙÆ® »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

ÀÌ ¼½¼Ç¿¡¼­´Â ´ãµµ ½ºÅÙÆ® ½ÃÀå º¸°í¼­ÀÇ ±¹°¡ ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °í°´À» ½Äº°Çϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Áö¿ª Àü¸ÁÀ» ´Ù·ç¸ç ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ ¹àÈü´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ´ãµµ ½ºÅÙÅä »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °³¿ä : Á¦Ç° À¯Çüº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : Á¦Ç° À¯Çüº°
  • ±Ý¼Ó
  • Æú¸®¸Ó

Á¦6Àå ¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ¿ëµµº°
  • ¾Ç¼º ´ãµµ Æó¼â
  • ¾ç¼º ´ãµµ ÇùÂø
  • ´ãµµ ¸®Å©
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä : ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø/Ŭ¸®´Ð
  • ¿Ü·¡ ¼­ºñ½º
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ´ãµµ ½ºÅÙÆ® ±â¾÷ÀÇ °æÀï ±¸µµ

  • ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ¡¤Çù·Â¡¤ÇùÁ¤
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç°ÀÇ ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Boston Scientific Corporation
  • Cook Medical
  • Olympus Corporation
  • Medtronic
  • C.R. Bard(Becton Dickinson & Company)
  • Conmed Corporation
  • Merit Medical Systems Inc.
  • Cordis Corporation(Cardinal Health)
KSA 24.08.26

The global demand for Biliary Stents Market is presumed to reach the market size of nearly USD 793.77 Million by 2032 from USD 482.79 Million in 2023 with a CAGR of 5.68% under the study period 2024-2032.

Biliary stents are medical devices used to maintain the patency of the bile duct in patients with obstructive biliary conditions. These stents are commonly employed to treat blockages caused by tumors, stones, or strictures and are essential for managing conditions such as cholangiocarcinoma, pancreatic cancer, and choledocholithiasis. These stents are typically inserted endoscopically and come in various materials, including plastic and metal (e.g., self-expanding metal stents). Plastic stents are generally used for short-term management and are less expensive, while metal stents are preferred for long-term use due to their durability and reduced need for replacement. Using these stents helps alleviate symptoms, improve bile flow, and enhance the quality of life for patients by preventing complications such as jaundice and cholangitis.

MARKET DYNAMICS

The biliary stents market is expanding due to the increasing incidence of biliary tract disorders and cancers, such as pancreatic and bile duct cancers, necessitating effective management solutions. As the global population ages and the prevalence of such conditions rises, there is a growing demand for biliary stenting procedures to alleviate obstructions and improve patient outcomes. Technological advancements in stent design are also contributing to market growth. Innovations such as self-expanding metal stents, biodegradable stents, and advancements in coating technologies are enhancing the efficacy and safety of biliary stents. These improvements lead to better patient outcomes and longer-lasting solutions, driving demand for advanced stenting options.

The rising prevalence of lifestyle-related diseases, such as obesity & diabetes, which increase the risk of biliary disorders, is further fuelling market growth. Additionally, the growing focus on minimally invasive procedures and the development of endoscopic techniques are expanding the market growth. Opportunities also arise from the increasing number of healthcare facilities and the expansion of medical infrastructure in emerging markets. Regions such as Asia-Pacific and Latin America are experiencing growth in healthcare investments and improved access to advanced medical technologies, which drives market growth. Furthermore, partnerships between stent manufacturers and healthcare providers foster innovation and enhance product offerings. Collaborative research and development efforts lead to the introduction of novel stent technologies that address clinical challenges and improve patient care. However, high costs associated with advanced biliary stents and potential complications related to stent placement and maintenance can hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biliary Stents. The growth and trends of Biliary Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biliary Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Metal
  • Polymer

By Application

  • Malignant Biliary Obstruction
  • Benign Biliary Strictures
  • Biliary Leak
  • Others

By End-user

  • Hospitals/Clinics
  • Ambulatory Services
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biliary Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biliary Stents market include Boston Scientific Corporation, Cook Medical, Olympus Corporation, Medtronic, C.R. Bard (Becton, Dickinson & Company), Conmed Corporation, Merit Medical Systems Inc., Cordis Corporation (Cardinal Health). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BILIARY STENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BILIARY STENTS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Metal Historic and Forecast Sales By Regions
  • 5.4. Polymer Historic and Forecast Sales By Regions

6. GLOBAL BILIARY STENTS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Malignant Biliary Obstruction Historic and Forecast Sales By Regions
  • 6.4. Benign Biliary Strictures Historic and Forecast Sales By Regions
  • 6.5. Biliary Leak Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL BILIARY STENTS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals/Clinics Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Services Historic and Forecast Sales By Regions
  • 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL BILIARY STENTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BILIARY STENTS COMPANIES

  • 9.1. Biliary Stents Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BILIARY STENTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Boston Scientific Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Cook Medical
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Olympus Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Medtronic
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. C.R. Bard (Becton
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Dickinson & Company)
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Conmed Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Merit Medical Systems Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Cordis Corporation (Cardinal Health)
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦